Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays.
As compared to hematopoietic stem cell transplantation (HSCT) with HLA genotypically identical donors, phenotypically matched unrelated HSCT is associated with lower survival. Serologically undisclosed HLA disparities account for the increased rate of post-transplant complications. With more than 1300 alleles currently identified, high-resolution molecular typing techniques have to be applied to distinguish the extensive degree of allelic polymorphism of the HLA system. Whereas a HLA-ABDR-serologically identical donor can be identified in the International Registry for >90% of the patients, only half of them can benefit of a highly compatible donor if donor selection is based on allele level matching for HLA-A/B/Cw/DRB1/B3/B5/DQB1 loci. During the last 10 years, we identified only approximately 20% of all known HLA alleles in the searches for our mainly Caucasoid patients. Rare alleles (i.e. alleles that represent <1% of a given serotype) do not have a major impact in patient/donor matching. Most of the incompatibilities are clustered in a limited number of serotypes that can be targeted first during the searches. However, due to linkage disequilibrium (e.g. B-Cw or DRB1-DQB1), incompatibilities at a given locus are often associated with disparities at adjacent loci. In vitro cellular assays such as the cytotoxic T-lymphocyte precursor frequency (CTLpf) analysis may contribute in discriminating functionally relevant HLA class I disparities, as well as minor antigen mismatches in case of sensitized donors. When a rare variant or an uncommon association in the patient's HLA haplotype has been found, the tissue typing laboratory may recommend considering a mismatched donor early in the search procedure instead of continuing a search with a low probability of success.
Tiercy
Jean-Marie
JM
National Reference Laboratory for Histocompatibility, University Hospital, Geneva, Switzerland. jean-marie.tiercy@medecine.unige.ch
Villard
Jean
J
Roosnek
Eddy
E
D000483:Alleles; D016026:Bone Marrow Transplantation; D003601:Cytotoxicity Tests, Immunologic; D005787:Gene Frequency; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D015810:Linkage Disequilibrium; D011110:Polymorphism, Genetic; D012042:Registries; D012699:Serology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014019:Tissue Donors
D006680:HLA Antigens